|Quantity Discounts||1 - 2|
|3 - 4|
|5 - 6|
|7 - 9|
|10 - 9999|
Four Hot Topics in FDA Regulation & Compliance: Opioids, Biosimilars, Right-to-Try and Dietary Supplements
Want to attend the live webinar on May 29? Click here to register.
There’s the opioid initiative and the FDA’s opioid task force. There’s right-to-try, biosimilars and dietary-supplement regulation. And host of other changes from the FDA, Congress, the White House and even on the state level.
Join noted FDA legal scholar Roseann B. Termini Esq. for the real skinny on four top issues. You’ll discover everything you need to know … in just 90 minutes.
From drugs to biotech, devices to diagnostics, every FDA-regulated player could do with a crystal ball. We offer the closest thing.
Roseann B. Termini Esq. boasts 30+ years practicing food and drug law. She’s also a respected author and commentator and first-ever winner of the Plain English Award. Her 12-volume handbook series Food & Drug Law is now in its tenth edition. She initiated the inaugural online food and drug law courses at Widener University School of Law and direct-to-consumer promotion at St. Joseph’s University executive program. With a legal career that started with an appellate clerkship and has encompassed both government and private-sector work, she sees food and drug law from all sides.
Copyright ©2019. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing